Observe Medical ASA
OBSRV.XOSL
Observe Medical ASA is a Norway-based medtech company that develops, markets, and sells innovative medical technology products for global healthcare markets. Specializing in urine output measurement, anesthesiology, ICUs, and wound care, it offers key products like Sippi, a CE-marked digital and automated system for precise urine monitoring and biofilm control; Biim, a wireless pocketable ultrasound device for point-of-care imaging to guide needle and catheter insertions; and the Unometer portfolio, including Unometer Safeti Plus, Unometer 500, and AbdoPressure for manual urine drainage, collection, and intra-abdominal pressure measurement. Founded in 2009 and headquartered in Oslo with R&D in Gothenburg, Sweden, the company operates through subsidiaries and a global distributor network, serving patients, healthcare professionals, and hospitals primarily in Norway, Sweden, the US, and Europe. With a lean team of about five employees led by CEO Jorgen Mann, Observe Medical ASA focuses on improving patient outcomes, clinical data accuracy, and health economics through scalable product commercialization.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
NOK 19M
▲ +9.2% YoY
Net Income (TTM)
-NOK 49M
▲ +17.2% YoY
Op. Margin
-198.50%
▲ +59.2pp YoY
ROIC
-35.72%
▼ -0.9pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-NOK 26M
▲ +11.3% YoY
Op. Cash Flow (TTM)
-NOK 25M
▲ +12.0% YoY
Net Debt
NOK 19M
Cash & Equiv.
NOK 12M
3Y CAGR: -1.2%
Continue Research
Peers
Medical Devices · Pick stocks to compare with OBSRV.XOSL
Observe Medical ASA (OBSRV.XOSL) in four numbers
Questions about Observe Medical ASA
Is Observe Medical ASA (OBSRV.XOSL) overvalued?
At €0.07, Observe Medical ASA's price is 157% above the €0.03 a share fair value that Intrinsiqq's calculator gets from its revenue. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.
What is Observe Medical ASA's fair value?
Intrinsiqq's calculator puts Observe Medical ASA's fair value at €0.03 a share. It grows revenue per share 0% a year for 5 years, applies an exit P/S of 1.6, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of €0.02. Every input can be changed on the Intrinsic Value tab.
Is Observe Medical ASA a high-quality business?
Observe Medical ASA scores 15 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 6 checks computed from company filings. Its best check is margin trend at +104.5pp, and its weakest is return on capital at -35.7%. The Quality tab shows every check against its target.
Does Observe Medical ASA (OBSRV.XOSL) pay a dividend?
No. Observe Medical ASA (OBSRV.XOSL) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: company filings. Price: last close 11 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing OBSRV.XOSL
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.